DiaMedica Therapeutics Ratios (2018-2019) | DMAC

Ratios Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019
Profitability
EBT Margin -266.00%
EBIT Margin -297.40%
EBITDA Margin -277.40%
Operating Margin -297.40%
Net Margin -277.40%
FCF Margin -371.80%
Efficiency
Assets Average 16.92M14.15M11.92M
Equity Average 6.05M4.73M10.57M15.47M12.80M10.70M
Invested Capital 6.75M5.36M4.11M17.02M13.91M11.70M9.70M
Leverage & Solvency
Equity Ratio 0.930.900.910.88
Valuation
Enterprise Value -6.71M-5.73M-3.90M22.52M22.15M30.58M33.48M32.66M
Market Capitalization 39.34M35.87M41.54M43.22M32.66M
Return Ratios
Return on Capital Employed -0.57%-0.74%-1.02%
Return on Assets -0.49%-0.64%-0.85%
Return on Equity -0.54%-0.54%-0.71%-0.95%